Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-2.0200 (-100.00%)
At close: Nov 21, 2025

ZHYBF Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Operating Revenue
2.011.662.331.641.22
Other Revenue
0.26----
2.281.662.331.641.22
Revenue Growth (YoY)
37.03%-28.60%42.38%34.09%0.17%
Cost of Revenue
0.210.140.420.280.26
Gross Profit
2.071.521.911.350.96
Selling, General & Admin
1.312.61.911.160.87
Research & Development
0.490.530.680.210.18
Operating Expenses
1.813.122.591.371.05
Operating Income
0.27-1.61-0.69-0.01-0.09
Interest Expense
-0.08-0.05-0.04-0.02-0.01
Interest & Investment Income
0.020000
Other Non Operating Income (Expenses)
0.060.070.050.010
EBT Excluding Unusual Items
0.27-1.59-0.67-0.03-0.09
Gain (Loss) on Sale of Assets
--0.09---
Pretax Income
0.27-1.68-0.67-0.03-0.09
Income Tax Expense
-0-0.010.01--
Earnings From Continuing Operations
0.27-1.67-0.68-0.03-0.09
Earnings From Discontinued Operations
--0.54-0.44--
Net Income to Company
0.27-2.2-1.13-0.03-0.09
Minority Interest in Earnings
0.030.05---
Net Income
0.3-2.15-1.13-0.03-0.09
Net Income to Common
0.3-2.15-1.13-0.03-0.09
Shares Outstanding (Basic)
1818171717
Shares Outstanding (Diluted)
1818171717
Shares Change (YoY)
1.85%2.21%0.81%2.74%3.33%
EPS (Basic)
0.02-0.12-0.07-0.00-0.01
EPS (Diluted)
0.02-0.12-0.07-0.00-0.01
Free Cash Flow
-0.75-1.05-0.260.3-0.15
Free Cash Flow Per Share
-0.04-0.06-0.010.02-0.01
Gross Margin
90.94%91.30%81.95%82.76%78.93%
Operating Margin
11.70%-96.62%-29.45%-0.89%-7.01%
Profit Margin
13.26%-129.27%-48.34%-1.71%-7.16%
Free Cash Flow Margin
-32.74%-63.02%-10.96%18.56%-12.64%
EBITDA
0.27-1.6-0.68-0.01-0.08
EBITDA Margin
11.79%-96.39%-29.22%-0.53%-6.50%
D&A For EBITDA
000.010.010.01
EBIT
0.27-1.61-0.69-0.01-0.09
EBIT Margin
11.70%-96.62%-29.45%-0.89%-7.01%
Revenue as Reported
2.281.662.33--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.